WallStreetZenWallStreetZen

NYSE: CNMD
Conmed Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Conmed earnings were $64.1M for the trailing 12 months ending Sep 30, 2025, with -51.9% growth year over year. The latest CNMD earnings report on Sep 30, 2025 announced Q3 2025 earnings of $2.9M, down 86.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CNMD reported annual earnings of $132.4M, with 105.4% growth. The next CNMD earnings date is Jan 29, 2026.

CNMD past earnings growth

How has CNMD's earnings growth performed historically?

Company
-51.87%
Industry
49%
Market
55.32%
CNMD's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
CNMD's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
CNMD's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

CNMD earnings history

Current Revenue
$1.3B
Current Earnings
$64.1M
Current Profit Margin
4.8%
CNMD's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

CNMD Return on Equity

Current Company
6.5%
Current Industry
13.3%
Current Market
35.8%
CNMD's Return on Equity (6.5%)... subscribe to Premium to read more.
High Return on Equity Performance

CNMD undefined

Current Company
2.8%
Current Industry
7.8%
CNMD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CNMD announces earnings.

CNMD undefined

Current Company
5.88%
Current Industry
8.5%
CNMD has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CNMD vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CNMD$135.36M$64.07M+152.68%$2.06
BBNX-$75.38M-$77.84MN/A-$4.39
AHCO$679.89M$82.24M-51.73%$0.56
IRMD$27.89M$21.18M+36.69%$1.67
SSII-$11.79M-$17.11MN/A-$0.09
View Top Medical Device Stocks

CNMD earnings dates

Next earnings date
Jan 29, 2026

Conmed Earnings Reports & History FAQ

What were Conmed's earnings last quarter?

On CNMD's earnings call on Invalid Date, Conmed (NYSE: CNMD) reported Q3 2025 earnings per share (EPS) of $0.09, up 94.34% year over year. Total CNMD earnings for the quarter were $2.86 million. In the same quarter last year, Conmed's earnings per share (EPS) was $1.59.

If you're new to stock investing, here's how to buy Conmed stock.

When does Conmed report earnings?

The next CNMD earnings date is Invalid Date. Add CNMD to your watchlist to be reminded of Conmed's next earnings date.

Is Conmed profitable or losing money?

As of the last Conmed earnings report, Conmed is currently profitable. Conmed's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $64.07 million, a 51.37% decrease year over year.

What was CNMD's earnings growth in the past year?

As of Conmed's earnings date in Invalid Date, Conmed's earnings has grown -51.87% year over year. This is 100.87 percentage points lower than the US Medical Devices industry earnings growth rate of 49%. CNMD earnings in the past year totalled $64.07 million.

What are Conmed's earnings expectations?

The current EPS estimate for Conmed's earnings report in Invalid Date is $1.33.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.